Buscar resultados de ensayos clínicos
Scleroderma, Diffuse - 20 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis Condición: Scleroderma, Diffuse Fecha: 2007-01-29 Intervenciones: Drug: N-acetylcysteine (NAC) |
Recruiting |
Nombre del estudio: Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis Condición:
|
Recruiting |
Nombre del estudio: Scleroderma Registry & Repository at the Hospital for Special Surgery Condición: Scleroderma Fecha: 2012-08-01 |
Terminated |
Nombre del estudio: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2007-01-03 Intervenciones:
|
Completed |
Nombre del estudio: Nilotinib in the Treatment of Systemic Sclerosis Condición: Systemic Sclerosis Fecha: 2010-07-01 Intervenciones: Drug: Nilotinib (Tasigna) Patients will be treated with Nilotinib 400 mg two times a day for 6 months. |
Active, not recruiting |
Nombre del estudio: Taking Charge of Systemic Sclerosis Condición: Scleroderma Fecha: 2015-05-22 Intervenciones:
|
Completed |
Nombre del estudio: Morbidity and Mortality Follow Up for the Scleroderma Lung Study Condición: Scleroderma Fecha: 2013-01-04 Intervenciones: Other: Followup survey |
Completed |
Nombre del estudio: Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Condición: Systemic Sclerosis Fecha: 2007-11-07 Intervenciones: Drug: Imatinib Mesylate In initial phase, patients will be treated with Gleevec 400 mg daily for 12 mont |
Completed |
Nombre del estudio: Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis Condición: Systemic Sclerosis Fecha: 2008-04-25 |
Recruiting |
Nombre del estudio: Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis Condición: Scleroderma Fecha: 2012-06-18 Intervenciones: Drug: Campath Pediatric patients with dcSSc are eligible for the clinical trial if they fulfill the incl |